Neurologic Abnormalities of Lyme Disease: Successful Treatment with High-Dose Intravenous Penicillin

  1. ALLEN C. STEERE, M.D.;
  2. PACHNER ANDREW R., M.D.; and
  3. STEPHEN E. MALAWISTA, M.D.
  1. New Haven, Connecticut

    Abstract

    Twelve patients were treated with high-dose intravenous penicillin for neurologic abnormalities of Lyme disease. Headache, stiff neck, and radicular pain usually began to subside by the second day of therapy and were often gone by 7 to 10 days. Five of the 12 patients continued to have intermittent mild headache for several more weeks, but no patient relapsed after therapy was stopped. Compared to 15 previous patients treated with prednisone alone, the duration of meningitic symptoms was significantly shorter in those given penicillin (mean duration, 1 versus 29 weeks, p < 0.000001). However, in both groups, a mean of 7 to 8 weeks was required for complete recovery of motor deficits. Despite antibiotic therapy, 3 of the 12 patients treated with penicillin continued to have frequent arthralgias, musculoskeletal pain, and fatigue. We conclude that high-dose intravenous penicillin is effective therapy for neurologic abnormalities of Lyme disease.

    Article and Author Information

    • ▸From the Departments of Internal Medicine and Neurology, Yale University School of Medicine; New Haven, Connecticut.

    • Grant support: in part by U. S. Public Health Service Grants AM-20358, AM-07107, AM-5639, RR-05443, and RR-00125, and the Arthritis Foundation and its Connecticut Chapter.

    • ▸Requests for reprints should be addressed to Allen C. Steere, M.D.; Department of Internal Medicine, Yale University School of Medicine; 333 Cedar Street; New Haven, CT 06510.

    « Previous | Next Article »Table of Contents